IRRAS Provides Update on CE Mark Re-Certification of IRRAflow®
- Company’s Notified Body has requested clarifications and updates of certain previous older reports regarding IRRAflow device -- US, other global markets, and worldwide regulatory submissions shall remain the main focus for the rest of the year -- Previously communicated 2021 financial objectives remain -Stockholm, April 24, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical technology company focused on developing and commercializing innovative solutions for neurocritical care, announced today that it received a response from G-MED, its designated European